Two-step approaches for synthesizing proportions in a meta-analysis require first transforming the proportions to a scale where their distribution across studies can be approximated by a normal distribution. Commonly used transformations include the log, logit, arcsine, and Freeman-Tukey double-arcsine transformations. Alternatively, a generalized linear mixed model (GLMM) can be fit directly on the data using the exact binomial likelihood. Unlike popular two-step methods, this accounts for uncertainty in the within-study variances without a normal approximation and does not require an ad hoc correction for zero counts. However, GLMMs require choosing a link function; we illustrate how the AIC can be used to choose the best-fitting link when different link functions give different results. We also highlight how misspecification of the link function can introduce bias; using an empirical sandwich estimator for the standard error may not sufficiently avoid undercoverage due to link function misspecification. We demonstrate the application of GLMMs and choice of link function using data from a systematic review on the prevalence of fever in children with COVID-19.
{"title":"Choice of Link Functions for Generalized Linear Mixed Models in Meta-Analyses of Proportions.","authors":"Lianne K Siegel, Milena Silva, Lifeng Lin, Yong Chen, Yu-Lun Liu, Haitao Chu","doi":"10.1177/26320843231224808","DOIUrl":"10.1177/26320843231224808","url":null,"abstract":"<p><p>Two-step approaches for synthesizing proportions in a meta-analysis require first transforming the proportions to a scale where their distribution across studies can be approximated by a normal distribution. Commonly used transformations include the log, logit, arcsine, and Freeman-Tukey double-arcsine transformations. Alternatively, a generalized linear mixed model (GLMM) can be fit directly on the data using the exact binomial likelihood. Unlike popular two-step methods, this accounts for uncertainty in the within-study variances without a normal approximation and does not require an <i>ad hoc</i> correction for zero counts. However, GLMMs require choosing a link function; we illustrate how the AIC can be used to choose the best-fitting link when different link functions give different results. We also highlight how misspecification of the link function can introduce bias; using an empirical sandwich estimator for the standard error may not sufficiently avoid undercoverage due to link function misspecification. We demonstrate the application of GLMMs and choice of link function using data from a systematic review on the prevalence of fever in children with COVID-19.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"6 1","pages":"13-23"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142820442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-04DOI: 10.1177/26320843231212427
Kelsey L Schertz, Megan Petrik, Mariah Branson, Steven S Fu, Alexander J Rothman, Abbie Begnaud, Anne M Joseph
Background Clinical trials involving pharmacologic or behavioral treatments often assess depression and suicidal ideation for purposes of screening, baseline assessment of potential moderators or mediators of treatment, or as a study outcome, even if the primary condition under study is not a mental health disorder. Suicide risk management in the context of clinical research poses significant clinical, ethical, and practical challenges, and the literature provides little guidance with respect to outcomes of suicide risk management protocols (SRMPs) or suicide risk assessment instruments deployed in the clinical research setting. Methods We report our experience using a novel SRMP in the Program for Lung Cancer Screening and Tobacco Cessation (PLUTO) trial through in-person and remote interactions. Results An SRMP was developed for non-clinical research staff to assess and respond to participants who express suicidal ideation. Between September 2016 and April 2021, the SRMP was used 61 times for 59 individuals. The SRMP was activated by explicit probing of suicidal ideation in 46 of 61 uses (75%). Subject risk was categorized as high-risk in 6 of 61 SRMP uses (10%). Conclusion Our findings demonstrate a useful tool for the management of suicidal ideation and behavior in a clinical trial. Suicidal ideation may be endorsed by only a small number of study participants, however participant safety dictates the need to develop and implement a practical SRMP. These findings may be of relevance to researchers collecting patient reported outcomes remotely. Researchers should consider available resources for SRMPs during design and start-up phases of research.
{"title":"Disclosure of suicidal ideation in non-psychiatric clinical research: Experience using a novel suicide risk management algorithm in a multi-center smoking cessation trial","authors":"Kelsey L Schertz, Megan Petrik, Mariah Branson, Steven S Fu, Alexander J Rothman, Abbie Begnaud, Anne M Joseph","doi":"10.1177/26320843231212427","DOIUrl":"https://doi.org/10.1177/26320843231212427","url":null,"abstract":"Background Clinical trials involving pharmacologic or behavioral treatments often assess depression and suicidal ideation for purposes of screening, baseline assessment of potential moderators or mediators of treatment, or as a study outcome, even if the primary condition under study is not a mental health disorder. Suicide risk management in the context of clinical research poses significant clinical, ethical, and practical challenges, and the literature provides little guidance with respect to outcomes of suicide risk management protocols (SRMPs) or suicide risk assessment instruments deployed in the clinical research setting. Methods We report our experience using a novel SRMP in the Program for Lung Cancer Screening and Tobacco Cessation (PLUTO) trial through in-person and remote interactions. Results An SRMP was developed for non-clinical research staff to assess and respond to participants who express suicidal ideation. Between September 2016 and April 2021, the SRMP was used 61 times for 59 individuals. The SRMP was activated by explicit probing of suicidal ideation in 46 of 61 uses (75%). Subject risk was categorized as high-risk in 6 of 61 SRMP uses (10%). Conclusion Our findings demonstrate a useful tool for the management of suicidal ideation and behavior in a clinical trial. Suicidal ideation may be endorsed by only a small number of study participants, however participant safety dictates the need to develop and implement a practical SRMP. These findings may be of relevance to researchers collecting patient reported outcomes remotely. Researchers should consider available resources for SRMPs during design and start-up phases of research.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"12 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135774560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: A substantial increase in the incidence of immediate release fentanyl (IRF) use was reported in Spain from 2012 to 2017. Purpose: This study aimed to investigate the relationship dynamically with cancer incidence in order to provide empirical evidence of inappropriate use of IRF with respect to the pathology. Research design: A vector autoregresive (VAR) model was constructed using data from a nationwide electronic healthcare record database in primary care in Spain (BIFAP) according to the following step procedure: (1) split data into training data for modelling and test for validation (2) assessing for time series stationarity; (3) selecting lag-length; (4) building the VAR model; (5) assessing residual autocorrelation; (6) checking stability of the VAR system; (7) evaluating Granger causality; (8) impulse response analysis and forecast error variance decomposition (9) prediction performance with validation data. Results: The analysis showed a strong and linear correlation between IRF and cancer (Pearson correlation coefficient: 0.594 (95% CI: 0.420–0.726). Two VAR models, VAR (2) and VAR (11) were selected and compared. All tests performed for both models satisfied assumptions for stability, predictability and accuracy. Granger causality revealed cancer incidence is a good predictor for IRF use. VAR (2) seemed to be slightly more accurate, according to the RMSE of the test data. Conclusions: This study demonstrates that using a robust and structured VAR modelling approach, is able to estimate dynamics associations, involving IRF use and cancer incidence.
{"title":"Dynamic relationship among immediate release fentanyl use and cancer incidence: A multivariate time-series analysis using vector autoregressive models","authors":"Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodríguez-Pascual, Pilar Rayón-Iglesias, Dolores Montero-Corominas, Consuelo Huerta-Álvarez","doi":"10.1177/26320843231206357","DOIUrl":"https://doi.org/10.1177/26320843231206357","url":null,"abstract":"Background: A substantial increase in the incidence of immediate release fentanyl (IRF) use was reported in Spain from 2012 to 2017. Purpose: This study aimed to investigate the relationship dynamically with cancer incidence in order to provide empirical evidence of inappropriate use of IRF with respect to the pathology. Research design: A vector autoregresive (VAR) model was constructed using data from a nationwide electronic healthcare record database in primary care in Spain (BIFAP) according to the following step procedure: (1) split data into training data for modelling and test for validation (2) assessing for time series stationarity; (3) selecting lag-length; (4) building the VAR model; (5) assessing residual autocorrelation; (6) checking stability of the VAR system; (7) evaluating Granger causality; (8) impulse response analysis and forecast error variance decomposition (9) prediction performance with validation data. Results: The analysis showed a strong and linear correlation between IRF and cancer (Pearson correlation coefficient: 0.594 (95% CI: 0.420–0.726). Two VAR models, VAR (2) and VAR (11) were selected and compared. All tests performed for both models satisfied assumptions for stability, predictability and accuracy. Granger causality revealed cancer incidence is a good predictor for IRF use. VAR (2) seemed to be slightly more accurate, according to the RMSE of the test data. Conclusions: This study demonstrates that using a robust and structured VAR modelling approach, is able to estimate dynamics associations, involving IRF use and cancer incidence.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135944365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1177/26320843231191835
{"title":"Editorial","authors":"","doi":"10.1177/26320843231191835","DOIUrl":"https://doi.org/10.1177/26320843231191835","url":null,"abstract":"","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"123 - 123"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49162009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01Epub Date: 2022-12-21DOI: 10.1177/26320843221147855
Victoria Yorke-Edwards, Carlos Diaz-Montana, Macey L Murray, Matthew R Sydes, Sharon B Love
Background: Over the last decade, there has been an increasing interest in risk-based monitoring (RBM) in clinical trials, resulting in a number of guidelines from regulators and its inclusion in ICH GCP. However, there is a lack of detail on how to approach RBM from a practical perspective, and insufficient understanding of best practice.
Purpose: We present a method for clinical trials units to track their metrics within clinical trials using descriptive statistics and visualisations.
Research design: We suggest descriptive statistics and visualisations within a SWAT methodology.
Study sample: We illustrate this method using the metrics from TEMPER, a monitoring study carried out in three trials at the MRC Clinical Trials Unit at UCL.
Data collection: The data collection for TEMPER is described in DOI: 10.1177/1740774518793379.
Results: We show the results and discuss a protocol for a Study-Within-A-Trial (SWAT 167) for those wishing to use the method.
Conclusions: The potential benefits metric tracking brings to clinical trials include enhanced assessment of sites for potential corrective action, improved evaluation and contextualisation of the influence of metrics and their thresholds, and the establishment of best practice in RBM. The standardisation of the collection of such monitoring data would benefit both individual trials and the clinical trials community.
{"title":"Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics.","authors":"Victoria Yorke-Edwards, Carlos Diaz-Montana, Macey L Murray, Matthew R Sydes, Sharon B Love","doi":"10.1177/26320843221147855","DOIUrl":"10.1177/26320843221147855","url":null,"abstract":"<p><strong>Background: </strong>Over the last decade, there has been an increasing interest in risk-based monitoring (RBM) in clinical trials, resulting in a number of guidelines from regulators and its inclusion in ICH GCP. However, there is a lack of detail on how to approach RBM from a practical perspective, and insufficient understanding of best practice.</p><p><strong>Purpose: </strong>We present a method for clinical trials units to track their metrics within clinical trials using descriptive statistics and visualisations.</p><p><strong>Research design: </strong>We suggest descriptive statistics and visualisations within a SWAT methodology.</p><p><strong>Study sample: </strong>We illustrate this method using the metrics from TEMPER, a monitoring study carried out in three trials at the MRC Clinical Trials Unit at UCL.</p><p><strong>Data collection: </strong>The data collection for TEMPER is described in <i>DOI: 10.1177/1740774518793379</i>.</p><p><strong>Results: </strong>We show the results and discuss a protocol for a Study-Within-A-Trial (SWAT 167) for those wishing to use the method.</p><p><strong>Conclusions: </strong>The potential benefits metric tracking brings to clinical trials include enhanced assessment of sites for potential corrective action, improved evaluation and contextualisation of the influence of metrics and their thresholds, and the establishment of best practice in RBM. The standardisation of the collection of such monitoring data would benefit both individual trials and the clinical trials community.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 4","pages":"124-135"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615148/pdf/EMS187694.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41143086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Editorial","authors":"J. Visagie","doi":"10.5784/39-1-764","DOIUrl":"https://doi.org/10.5784/39-1-764","url":null,"abstract":"","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"86 - 86"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43475782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-03DOI: 10.1177/26320843231167496
Luke E Peters, Jie Zhao, Scott Gelzinnis, Stephen R Smith, Jennifer Martin, P. Pockney
Background: High response rates for patient surveys are required in medical literature to ensure non-response bias is minimised. It is often difficult to achieve a satisfactory response rate as patient engagement in surveys is decreasing. A major barrier to phone surveys is getting patients to answer calls from unknown numbers. Purpose: To design a methodology which boosts response rates for telephone-based patient surveys. Research Design: We prospectively analysed the effectiveness of our methodology for increasing patient participation using caller ID and text messanging. Study Sample: Two waves totalling 1313 patients were contacted for participation in a patient survey for a descriptive quantitative and qualitative cohort study using our developed methadology. Data Analysis: We analysed the timepoints at which successful contact was made when using caller ID and text messanging. Results: We achieved a call answer rate of 85.4%, which was a 70.8% increase when compared to a similar patient cohort contacted via blocked caller ID (i.e. with privacy settings). Conclusion: We have developed a simple, inexpensive methodology which, when tested outside the Australian setting and for other projects, shows promise for increasing patient survey response rate.
{"title":"Use of caller ID and text messaging from cell phones to increase response rates in patient surveys","authors":"Luke E Peters, Jie Zhao, Scott Gelzinnis, Stephen R Smith, Jennifer Martin, P. Pockney","doi":"10.1177/26320843231167496","DOIUrl":"https://doi.org/10.1177/26320843231167496","url":null,"abstract":"Background: High response rates for patient surveys are required in medical literature to ensure non-response bias is minimised. It is often difficult to achieve a satisfactory response rate as patient engagement in surveys is decreasing. A major barrier to phone surveys is getting patients to answer calls from unknown numbers. Purpose: To design a methodology which boosts response rates for telephone-based patient surveys. Research Design: We prospectively analysed the effectiveness of our methodology for increasing patient participation using caller ID and text messanging. Study Sample: Two waves totalling 1313 patients were contacted for participation in a patient survey for a descriptive quantitative and qualitative cohort study using our developed methadology. Data Analysis: We analysed the timepoints at which successful contact was made when using caller ID and text messanging. Results: We achieved a call answer rate of 85.4%, which was a 70.8% increase when compared to a similar patient cohort contacted via blocked caller ID (i.e. with privacy settings). Conclusion: We have developed a simple, inexpensive methodology which, when tested outside the Australian setting and for other projects, shows promise for increasing patient survey response rate.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"150 - 155"},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46868128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-29DOI: 10.1177/26320843231167502
L. Spineli
Background Using evidence synthesis to design a clinical trial has long been advocated as the key against research waste. However, the relevant methodology does not deal with possible missing participants (MP) that may occur in a future trial. We illustrated the synergism of the baseline effects model and network meta-analysis (NMA) to predict the percentage of MP for a future trial. Methods We considered the network of a published systematic review as a case study. We applied the baseline effects model, followed by the relative effects model using Bayesian methods to predict the percentage of MP in each intervention when conducting NMA and a series of pairwise meta-analyses. We illustrated the posterior distribution of the predicted percentage MP under both synthesis methods alongside the MP reported in the corresponding trials for each intervention. Results Selecting different interventions for the baseline effects model yielded different predicted baseline effects and led to different predicted percentages of MP for the remaining interventions, highlighting the need to carefully pre-specifying the intervention for the baseline effects model. Both synthesis methods provided almost identical posterior distributions of predicted percentage MP for estimating similar summary odds ratios. There was great variability in the percentage of MP across the trials for each intervention, manifesting as considerable variability in the percentage difference in MP compared to NMA. Conclusions Incorporating predictions and absolute effects in the context of MP in NMA aids in determining the anticipated percentage of MP in the compared interventions to plan a future trial efficiently.
{"title":"Using network meta-analysis to predict the percentage of missing participants for a future trial","authors":"L. Spineli","doi":"10.1177/26320843231167502","DOIUrl":"https://doi.org/10.1177/26320843231167502","url":null,"abstract":"Background Using evidence synthesis to design a clinical trial has long been advocated as the key against research waste. However, the relevant methodology does not deal with possible missing participants (MP) that may occur in a future trial. We illustrated the synergism of the baseline effects model and network meta-analysis (NMA) to predict the percentage of MP for a future trial. Methods We considered the network of a published systematic review as a case study. We applied the baseline effects model, followed by the relative effects model using Bayesian methods to predict the percentage of MP in each intervention when conducting NMA and a series of pairwise meta-analyses. We illustrated the posterior distribution of the predicted percentage MP under both synthesis methods alongside the MP reported in the corresponding trials for each intervention. Results Selecting different interventions for the baseline effects model yielded different predicted baseline effects and led to different predicted percentages of MP for the remaining interventions, highlighting the need to carefully pre-specifying the intervention for the baseline effects model. Both synthesis methods provided almost identical posterior distributions of predicted percentage MP for estimating similar summary odds ratios. There was great variability in the percentage of MP across the trials for each intervention, manifesting as considerable variability in the percentage difference in MP compared to NMA. Conclusions Incorporating predictions and absolute effects in the context of MP in NMA aids in determining the anticipated percentage of MP in the compared interventions to plan a future trial efficiently.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"140 - 149"},"PeriodicalIF":0.0,"publicationDate":"2023-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48774129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-06DOI: 10.1177/26320843231162587
Nishadi Gamage, P. Ranasinghe, R. Jayawardena
Background When conducting reviews, obtaining unreported information by contacting corresponding authors via traditional methods of correspondence, such as email/postage has become increasingly challenging. Objective/s The current study aimed to identify the different non-traditional sources and approaches to obtain unreported data from respective authors of primary studies eligible for systematic reviews and meta-analyses. Methods Unreported data were obtained initially through traditional methods (email/telephone, searching forward citations of the articles, review of other publications of the same research team and perusal of authors’ institutional profiles). The second stage included communication through digital/social media, which comprised Facebook, ResearchGate, WhatsApp, Viber, LinkedIn, and the online Global Health Data Exchange (GHDx). Results During data extraction, 41 individual data items were missing/unreported, and we were able to identify 36 (87.8%) during data tracing, using both traditional (n = 10, 27.8%) and digital and social media-based (n = 26, 72.2%) methods. These 26 data items were identified through the following methods, (a) Facebook (n = 6), (b) ResearchGate (n = 3), (c) WhatsApp (n = 3), (d) Viber (n = 1), (e) LinkedIn (n = 1) and GHDx database (n = 12). Conclusion Digital/social media platforms were found to be more successful to obtain unreported data. We believe that a combination of both methods is likely to yield the best results in tracing missing data for systematic reviews. Journals should consider including social media links and non-institutional research profiles in addition to traditional methods for correspondence.
{"title":"Tracing data for systematic reviews and meta-analyses in the advanced age of digital and social media","authors":"Nishadi Gamage, P. Ranasinghe, R. Jayawardena","doi":"10.1177/26320843231162587","DOIUrl":"https://doi.org/10.1177/26320843231162587","url":null,"abstract":"Background When conducting reviews, obtaining unreported information by contacting corresponding authors via traditional methods of correspondence, such as email/postage has become increasingly challenging. Objective/s The current study aimed to identify the different non-traditional sources and approaches to obtain unreported data from respective authors of primary studies eligible for systematic reviews and meta-analyses. Methods Unreported data were obtained initially through traditional methods (email/telephone, searching forward citations of the articles, review of other publications of the same research team and perusal of authors’ institutional profiles). The second stage included communication through digital/social media, which comprised Facebook, ResearchGate, WhatsApp, Viber, LinkedIn, and the online Global Health Data Exchange (GHDx). Results During data extraction, 41 individual data items were missing/unreported, and we were able to identify 36 (87.8%) during data tracing, using both traditional (n = 10, 27.8%) and digital and social media-based (n = 26, 72.2%) methods. These 26 data items were identified through the following methods, (a) Facebook (n = 6), (b) ResearchGate (n = 3), (c) WhatsApp (n = 3), (d) Viber (n = 1), (e) LinkedIn (n = 1) and GHDx database (n = 12). Conclusion Digital/social media platforms were found to be more successful to obtain unreported data. We believe that a combination of both methods is likely to yield the best results in tracing missing data for systematic reviews. Journals should consider including social media links and non-institutional research profiles in addition to traditional methods for correspondence.","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"136 - 139"},"PeriodicalIF":0.0,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48348143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-01Epub Date: 2022-09-22DOI: 10.1177/26320843221128296
Catherine Knowlson, Puvan Tharmanathan, Catherine Arundel, Sophie James, Lydia Flett, Samantha Gascoyne, Charlie Welch, David Warwick, Joseph Dias
Background: RCTs often face issues such as slow recruitment, poor intervention adherence and high attrition, however the 2020/2021 COVID-19 pandemic intensified these challenges. Strategies employed by the DISC trial to overcome pandemic-related barriers to recruitment, treatment delivery and retention may be useful to help overcome routine problems.
Methods: A structured survey and teleconference with sites was undertaken. Key performance indicators in relation to recruitment, treatment delivery and retention were compared descriptively before and after the pandemic started. This was situated also in relation to qualitative opinions of research staff.
Results: Prior to the pandemic, retention was 93.6%. Increased support from the central trial management team and remote data collection methods kept retention rates high at 81.2% in the first 6 months of the pandemic, rising to 89.8% in the subsequent 6 months. Advertising the study to patients resulted in 12.8 patients/month enquiring about participation, however only six were referred to recruiting sites. Sites reported increased support from junior doctors resolved research nurse capacity issues. One site avoided long delays by using theatre space in a private hospital.
Conclusions: Recruitment post-pandemic could be improved by identification of barriers, increased support from junior doctors through the NIHR associate PI scheme and advertising. Remote back-up options for data collection can keep retention high while reducing patient and site burden. To future proof studies against similar disruptions and provide more flexibility for participants, we recommend that RCTs have a back-up option of remote recruitment, a back-up location for surgeries and flexible approaches to collecting data.
{"title":"Can learnings from the COVID-19 pandemic improve trial conduct post-pandemic? A case study of strategies used by the DISC trial.","authors":"Catherine Knowlson, Puvan Tharmanathan, Catherine Arundel, Sophie James, Lydia Flett, Samantha Gascoyne, Charlie Welch, David Warwick, Joseph Dias","doi":"10.1177/26320843221128296","DOIUrl":"10.1177/26320843221128296","url":null,"abstract":"<p><strong>Background: </strong>RCTs often face issues such as slow recruitment, poor intervention adherence and high attrition, however the 2020/2021 COVID-19 pandemic intensified these challenges. Strategies employed by the DISC trial to overcome pandemic-related barriers to recruitment, treatment delivery and retention may be useful to help overcome routine problems.</p><p><strong>Methods: </strong>A structured survey and teleconference with sites was undertaken. Key performance indicators in relation to recruitment, treatment delivery and retention were compared descriptively before and after the pandemic started. This was situated also in relation to qualitative opinions of research staff.</p><p><strong>Results: </strong>Prior to the pandemic, retention was 93.6%. Increased support from the central trial management team and remote data collection methods kept retention rates high at 81.2% in the first 6 months of the pandemic, rising to 89.8% in the subsequent 6 months. Advertising the study to patients resulted in 12.8 patients/month enquiring about participation, however only six were referred to recruiting sites. Sites reported increased support from junior doctors resolved research nurse capacity issues. One site avoided long delays by using theatre space in a private hospital.</p><p><strong>Conclusions: </strong>Recruitment post-pandemic could be improved by identification of barriers, increased support from junior doctors through the NIHR associate PI scheme and advertising. Remote back-up options for data collection can keep retention high while reducing patient and site burden. To future proof studies against similar disruptions and provide more flexibility for participants, we recommend that RCTs have a back-up option of remote recruitment, a back-up location for surgeries and flexible approaches to collecting data.</p>","PeriodicalId":74683,"journal":{"name":"Research methods in medicine & health sciences","volume":"4 1","pages":"50-60"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42414230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}